News & Media

The clinical neuropsychologist and assistant professor of medicine at the Icahn School of Medicine at Mount Sinai discussed the mechanisms behind brain fog from Long COVID and "treatments showing the most promise for Long COVID cognitive symptoms." In her conversation she notes, "We did just complete a pilot randomized clinical trial doing microtesla magnetic therapy (MMT), which is a novel device. We did the first-in-human study, and it showed potential benefits." Read the full article:

Microtesla Magnetic Therapy (MMT), a treatment delivered to the brain may also be associated with biological changes elsewhere in the body. Using blood samples from participants in its randomised, sham-controlled Long COVID trial, researchers identified biomarker changes associated with inflammation, cellular injury, and repair. Participants who received MMT showed a trend toward lower predicted brain age and whole-body age...The findings give Fareon a set of biological signals that can now be tested in larger studies.

A potential breakthrough has emerged from an unexpected corner of the medical field. Fareon, a clinical-stage biophysics company, today announced promising results for a novel therapy aimed at the debilitating cognitive impairment, or "brain fog," that plagues millions of Long COVID sufferers. The data, from a rigorous clinical trial led by the Icahn School of Medicine at Mount Sinai, suggests that a non-invasive headset delivering low-intensity magnetic fields may not just manage symptoms, but actually restore lost brain function.

Fareon's Microtesla Magnetic Therapy uses precisely calibrated, low intensity radiofrequency magnetic fields, delivered through a comfortable headset to activate biological pathways associated with repair and resilience—without systemic drug exposure. The therapy is administered at home, is noninvasive, and has demonstrated excellent tolerability across clinical studies. These findings build upon Fareon's previously reported randomized clinical trial results demonstrating improvements in working memory, verbal learning, processing speed, and emotional wellbeing.